Plasma and cerebrospinal fluid tau and neurofilament concentrations in rapidly progressive neurological syndromes: a neuropathology-based cohort

Serum Neurofilament Light Protein as a Marker for Diffuse Axonal Injury: Results from a Case Series Study

(2017) Johan Ljungqvist et al.   JOURNAL OF NEUROTRAUMA

Review: Tau in biofluids - relation to pathology, imaging and clinical features

(2017) H. Zetterberg   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

(2016) Bruno Dubois et al.   Alzheimers & Dementia

Cerebrospinal fluid real-time quaking-induced conversion is a robust and reliable test for sporadic creutzfeldt-jakob disease: An international study

(2016) Lynne I. McGuire et al.   ANNALS OF NEUROLOGY

The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature

(2016) Anja Hviid Simonsen et al.   Biomarkers in Medicine

Cerebrospinal fluid markers in the differentiation of molecular subtypes of sporadic Creutzfeldt−Jakob disease

(2016) K. Gmitterová et al.   EUROPEAN JOURNAL OF NEUROLOGY

Alzheimer's disease

(2016) Philip Scheltens et al.   LANCET

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

(2016) Bob Olsson et al.   LANCET NEUROLOGY

Plasma tau in Alzheimer disease

(2016) Niklas Mattsson et al.   NEUROLOGY

Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia

(2016) Jonathan D. Rohrer et al.   NEUROLOGY

CSF biomarkers in neurodegenerative and vascular dementias

(2016) Franc Llorens et al.   PROGRESS IN NEUROBIOLOGY

Neurochemical Aftermath of Repetitive Mild Traumatic Brain Injury

(2016) Pashtun Shahim et al.   JAMA Neurology

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study

(2016) Magnus Gisslén et al.   EBioMedicine

Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease

(2016) Petra Steinacker et al.   Scientific Reports

Serum neurofilament light protein predicts clinical outcome in traumatic brain injury

(2016) Pashtun Shahim et al.   Scientific Reports

A case of variably protease-sensitive prionopathy treated with doxycyclin

(2015) Hamid Assar et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Invited review: Neuropathology of tauopathies: principles and practice

(2015) G. G. Kovacs   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Association of Cerebrospinal Fluid Prion Protein Levels and the Distinction Between Alzheimer Disease and Creutzfeldt-Jakob Disease

(2015) Aline Dorey et al.   JAMA Neurology

Prevalence of mixed pathologies in the aging brain

(2014) Jasmin Rahimi et al.   Alzheimers Research & Therapy

Diagnostic Performance of Cerebrospinal Fluid Total Tau and Phosphorylated Tau in Creutzfeldt-Jakob Disease

(2014) Tobias Skillbäck et al.   JAMA Neurology

Population Screening for Variant Creutzfeldt-Jakob Disease Using a Novel Blood Test

(2014) Graham S. Jackson et al.   JAMA Neurology

Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation

(2013) M. Suarez-Calvet et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Biomarker Modeling of Alzheimer’s Disease

(2013) Clifford R. Jack et al.   NEURON

Plasma tau levels in Alzheimer's disease

(2013) Henrik Zetterberg et al.   Alzheimers Research & Therapy

Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA

(2012) Piero Parchi et al.   ACTA NEUROPATHOLOGICA

Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia

(2012) Peder Buchhave   ARCHIVES OF GENERAL PSYCHIATRY

Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt–Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years

(2012) Katharina Stoeck et al.   BRAIN

Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

(2012) Peter T. Nelson et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Neurofilaments as biomarkers in multiple sclerosis

(2012) Charlotte E Teunissen et al.   Multiple Sclerosis Journal

Injury markers predict time to dementia in subjects with MCI and amyloid pathology

(2012) I. A. van Rossum et al.   NEUROLOGY

Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: Results of a pilot study

(2012) Jeffrey Randall et al.   RESUSCITATION

Current concepts of neuropathological diagnostics in practice: neurodegenerative diseases

(2011) G.G. Kovacs et al.   CLINICAL NEUROPATHOLOGY

Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics

(2010) Gabor G. Kovacs et al.   ACTA NEUROPATHOLOGICA

Variably protease-sensitive prionopathy: A new sporadic disease of the prion protein

(2010) Wen-Quan Zou et al.   ANNALS OF NEUROLOGY

Distribution of apoptosis-related proteins in sporadic Creutzfeldt–Jakob disease

(2010) Gabor G. Kovacs et al.   BRAIN RESEARCH

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

(2010) Kaj Blennow et al.   Nature Reviews Neurology

Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies

(2009) Anna Ladogana et al.   JOURNAL OF NEUROLOGY